The Frost & Sullivan Digital Transformation Blog
A collection of expert insights and industry news to help you accelerate growth.
Featured
Sign Up
Sign up to get Frost & Sullivan’s best
and newest content delivered weekly to your inbox.
Scaling Trust in Cybersecurity: How Sophos Is Redefining MDR, AI, and Cyber Leadership
Joe Levy, Chief Executive Officer, Sophos, in conversation with Adrian Drozd, Associate Partner, Frost & Sullivan, and Lucas Ferreyra, Industry Principal, Cybersecurity Practice, Frost & Sullivan Download this Transformational Growth Leadership Discussion As...
Next-generation Data Centers: How Cooling Strategy Now Defines Leadership
AI is transforming the physical and operational limits of digital infrastructure. As AI models scale and hyperscale deployments expand, data centers are encountering significant thermal loads that challenge conventional cooling architectures. What was once treated as...
Centrical Receives Frost & Sullivan’s 2026 Global Transformational Innovation Leadership Recognition for Excellence in Performance Intelligence
Recognized for advancing performance intelligence through transformational innovation that enhances frontline productivity, engagement, and business outcomes.
Grundfos Pumps India Receives Frost & Sullivan’s 2026 Indian Company of the Year Recognition for Leadership in Sustainable Pumps for Industrial Water
The recognition highlights Grundfos Pumps India’s market leadership in sustainable pumps, industrial water management, and energy-efficient pumping solutions driven by digitalization and water stewardship.
BROWSE RECENT POSTS
Centrical Receives Frost & Sullivan’s 2026 Global Transformational Innovation Leadership Recognition for Excellence in Performance Intelligence
Recognized for advancing performance intelligence through transformational innovation that enhances frontline productivity, engagement, and business outcomes.
Centrical Receives Frost & Sullivan’s 2026 Global Transformational Innovation Leadership Recognition for Excellence in Performance Intelligence
Recognized for advancing performance intelligence through transformational innovation that enhances frontline productivity, engagement, and business outcomes.
Grundfos Pumps India Receives Frost & Sullivan’s 2026 Indian Company of the Year Recognition for Leadership in Sustainable Pumps for Industrial Water
The recognition highlights Grundfos Pumps India’s market leadership in sustainable pumps, industrial water management, and energy-efficient pumping solutions driven by digitalization and water stewardship.
Grundfos Pumps India Receives Frost & Sullivan’s 2026 Indian Company of the Year Recognition for Leadership in Sustainable Pumps for Industrial Water
The recognition highlights Grundfos Pumps India’s market leadership in sustainable pumps, industrial water management, and energy-efficient pumping solutions driven by digitalization and water stewardship.
Grundfos Pumps India Receives Frost & Sullivan’s 2026 Indian Company of the Year Recognition for Leadership in Sustainable Pumps for Industrial Water
The recognition highlights Grundfos Pumps India’s market leadership in sustainable pumps, industrial water management, and energy-efficient pumping solutions driven by digitalization and water stewardship.
Grundfos Pumps India Receives Frost & Sullivan’s 2026 Indian Company of the Year Recognition for Leadership in Sustainable Pumps for Industrial Water
The recognition highlights Grundfos Pumps India’s market leadership in sustainable pumps, industrial water management, and energy-efficient pumping solutions driven by digitalization and water stewardship.
Browse by Category
- All
- Big Data
- Cloud
- Customer Contact
- Consumer
- Digital Media
- Enterprise
- Mobile & Wireless
- The Internet of Things
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
10 Strategic Imperatives Reshaping ESG Platforms: What’s Driving the Shift in Compliance, Reporting, and Risk
Environmental, Social, and Governance (ESG) priorities are no longer confined to annual reports; they’re reshaping how businesses operate, allocate capital, and manage risk. What began as a compliance exercise is now a data-driven function influencing investor...
Global Light Vehicle Growth Opportunities for 2025: Strategies to Win in a Fragmented World
Achieving Success in 2025 and Beyond: A New Blueprint for Light Vehicle Growth After two years of strong rebound — 6.5% growth in 2023 and 4% in 2024 — the global light vehicle industry has returned to pre-pandemic production volumes. But beneath the surface of this...
Class I New Drug Pemefolacianine Completes Phase I Clinical Trial, Advancing Intraoperative Precision Diagnosis
Nanjing Nuoyuan Medical Devices Co., Ltd. (Nuoyuan Medical) has successfully completed a Phase I clinical trial in China for its independently developed Class I new drug, Pemefolacianine, with positive outcomes. As an innovative fluorescent imaging agent targeting...
Navigating the Chaos: Growth Opportunities That Will Define Automotive Success in 2025
2025 Isn’t Business as Usual. It’s Business Reimagined. Geopolitical chaos. Technology shifts. Global production realignment. The automotive industry isn’t just evolving — it’s accelerating into uncharted terrain. Unlike past years that were defined by recovery or...
Health & Wellness Technology Trends: Top Innovations Transforming Patient Outcomes in 2025
This blog is based on the Frost & Sullivan TechVision analysis Top 50 Emerging Technologies: 2025 Edition. For additional insights, contact [email protected]. As the global healthcare landscape evolves, the convergence of regenerative medicine, artificial...
Reimagining Global Healthcare: How Qure.ai is Scaling AI to a Billion Lives
A Conversation with Prashant Warier, Co-founder and CEO of Qure.ai, and Anantharaman Viswanathan, Research Director, Frost & Sullivan Download Frost & Sullivan’s Transformational Growth Leadership Interview with Prashant Warier, Co-founder and CEO of Qure.ai....
